A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）
Clinical trial NCT07191431 · RECRUITING
Trial details
- NCT number
- NCT07191431
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-22
- Primary completion
- 2027-09-02
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.